Dolutegravir Resistance in Malawi’s National HIV Treatment Program

Dolutegravir HIV drug resistance (HIVDR) data from Africa remain sparse. We reviewed HIVDR results of Malawians on dolutegravir-based antiretroviral therapy (November 2020–September 2021). Of 6462 eligible clients, 33 samples were submitted to South Africa, 27 were sequenced successfully, and 8 (30%...

Descripción completa

Detalles Bibliográficos
Autores principales: van Oosterhout, Joep J, Chipungu, Chifundo, Nkhoma, Lyse, Kanise, Hope, Hosseinipour, Mina C, Sagno, Jean Babtiste, Simon, Katherine, Cox, Carrie, Hoffman, Risa, Steegen, Kim, Matola, Bilaal W, Phiri, Sam, Jahn, Andreas, Nyirenda, Rose, Heller, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045949/
https://www.ncbi.nlm.nih.gov/pubmed/35493118
http://dx.doi.org/10.1093/ofid/ofac148

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9045949/
https://www.ncbi.nlm.nih.gov/pubmed/35493118
http://dx.doi.org/10.1093/ofid/ofac148

Ejemplares similares